ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
US Tech 100
18,062.00
-0.10%
Dow Jones
40,003.59
0.34%
Brent Oil
83.76
0.00%
Bitcoin
67,088.29
0.22%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. Armata Pharmaceuticals Inc (ARMP)

  7. Armata Pharmaceuticals Inc (ARMP) News

ARMP

Armata Pharmaceuticals (ARMP)

Armata Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:ARMP
DateTimeSourceHeadlineSymbolCompany
05/07/20244:25PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:ARMPArmata Pharmaceuticals Inc
05/07/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:ARMPArmata Pharmaceuticals Inc
03/04/20245:35PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:ARMPArmata Pharmaceuticals Inc
03/04/20244:03PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:ARMPArmata Pharmaceuticals Inc
01/23/20244:17PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansAMEX:ARMPArmata Pharmaceuticals Inc
12/26/20239:55PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
12/26/20239:55PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
12/26/20239:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
12/26/20239:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
12/26/20239:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
12/26/20239:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
12/26/20239:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
12/26/20239:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
11/15/20235:24PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansAMEX:ARMPArmata Pharmaceuticals Inc
09/22/20237:17PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
09/20/20238:00AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:ARMPArmata Pharmaceuticals Inc
08/14/20237:30AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:ARMPArmata Pharmaceuticals Inc
08/14/20237:15AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:ARMPArmata Pharmaceuticals Inc
08/03/20234:37PMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersAMEX:ARMPArmata Pharmaceuticals Inc
08/03/20234:35PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:ARMPArmata Pharmaceuticals Inc
08/03/20234:34PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:ARMPArmata Pharmaceuticals Inc
07/24/20234:30PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsAMEX:ARMPArmata Pharmaceuticals Inc
07/19/20234:30PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:ARMPArmata Pharmaceuticals Inc
07/19/20239:56AMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
07/11/20238:27AMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:ARMPArmata Pharmaceuticals Inc
07/11/20238:15AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:ARMPArmata Pharmaceuticals Inc
06/27/20234:31PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:ARMPArmata Pharmaceuticals Inc
05/12/20236:03AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:ARMPArmata Pharmaceuticals Inc
05/11/20234:07PMEdgar (US Regulatory)Quarterly Report (10-q)AMEX:ARMPArmata Pharmaceuticals Inc
03/16/20234:12PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:ARMPArmata Pharmaceuticals Inc
 Showing the most relevant articles for your search:AMEX:ARMP

Your Recent History

BIT
P1CMZ9
BNP Paribas Issuance
BIT
P1HX97
BNP Paribas Issuance
BIT
S29090
Societe Generale Effekten
AQSE
ZIN.GB
Zinc Media
AQSE
EDEN.GB
Eden Research
BIT
FARM
H-Farm
BIT
P13ZS5
BNP Paribas Issuance
BIT
P1CN37
BNP Paribas Issuance
BIT
ASC
Ascopiave
BIT
P17XJ0
BNP Paribas Issuance
BIT
P1AJA2
BNP Paribas Issuance
BIT
O8JPN8
Morgan Stanley BV
BIT
S21015
SG Issuer
BIT
AXA
Axa
BOV
NEMO3
SUZANO HOLD ON
BIT
P77112
BNP Paribas
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved